$PLBY Balance Sheet | Understand Stock

$PLBY

$1.13 +$0.04 (3.67%) Close

$PLBY Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Restricted cash
Receivables, net of $0.8 million and $0.7 million of allowance for credit losses as of June 30, 2026 and December 31, 2025, respectively
Inventory, net
Stock receivable
Prepaid expenses and other current assets
Assets held for sale
Total current assets

Restricted cash
Property and equipment, net
Operating right-of-use assets
Digital assets, net
Goodwill
Other intangible assets, net
Contract assets, net of current portion
Other noncurrent assets
Total assets
Liabilities and Equity
Current liabilities:
Accounts payable
Accrued agency fees and commissions
Deferred revenues, current portion
Long-term debt, current portion
Contingent consideration
Contingent consideration, at fair value
Operating lease liabilities, current portion
Liability pursuant to a stock repurchase agreement
Other current liabilities and accrued expenses
Liabilities held for sale
Total current liabilities

Deferred revenues, net of current portion
Long-term debt, net of current portion
Deferred tax liabilities, net
Operating lease liabilities, net of current portion
Mandatorily redeemable preferred stock, at fair value
Other noncurrent liabilities
Total liabilities
Redeemable noncontrolling interest
Mezzanine equity:
Series B convertible preferred stock, $0.0001 par value per share, 28,001 shares authorized, 0 issued and outstanding as of December 31, 2025; 28,001 shares authorized, 28,000.00001 issued and outstanding as of December 31, 2024
Redeemable noncontrolling interest
Stockholders’ equity:
Preferred stock, $0.0001 par value per share, 5,000,000 shares authorized, 50,000 shares designated Series A preferred stock, of which 0 shares were issued and outstanding as of December 31, 2024 and December 31, 2023
Common stock, par value $0.0001 per share, 400,000,000 shares authorized, 123,460,167 shares issued and 118,353,343 shares outstanding as of June 30, 2026; 400,000,000 shares authorized, 115,069,810 shares issued and 112,819,881 shares outstanding as of December 31, 2025
Treasury stock, at cost, 5,106,824 and 2,249,929 shares as of June 30, 2026 and December 31, 2025
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity
Noncontrolling interest (Note 9)
Total equity
Total liabilities and equity

Comments